主导性和衰退性干扰素玛受体1缺陷的临床特征
Susan E Dorman1, Capucine Picard, David Lammas
1Laboratory of Clinical Infectious Diseases, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Building 10, CRC B3-419, 10 Center Drive, MSC 1684, Bethesda, MD 20892-1684, USA.
递归的完全和主导的局部干扰素马受体1 (IFNgammaR1) 缺陷导致严重的真菌细菌感染. 与主导性缺乏症相比,衰退性缺乏症呈现出更早的发病和更严重的疾病.
科学领域:
- 免疫学 免疫学 免疫学
- 遗传学 是一个遗传学.
- 传染性疾病 传染性疾病
背景情况:
- 干扰素玛受体1 (IFNgammaR1) 缺陷是一种主要免疫缺陷.
- 它呈现出基主导和衰退突变,导致严重的真菌细菌感染.
研究的目的:
- 为了比较衰退性和主导性IFNgammaR1缺陷的临床特征.
- 为了将IFNGR1基因型与细胞响应和临床疾病相关联.
主要方法:
- 研究了一大批国际IFNgammaR1缺乏症患者队列.
- 通过病史,记录和遗传/免疫学评估收集数据.
主要成果:
- 22名患者患有衰退的完全缺乏症,38名患有主导的部分缺乏症.
- 这两种形式经常导致BCG和环境菌根菌病.
- 衰退性缺陷表现出较早的发病,更频繁和严重的真菌菌病发作,以及比主导性缺陷更低的生存率.
结论:
- 衰退性和主导性IFNgammaR1缺陷具有相关但可以区分的临床表型.
- 发病时的年龄,疾病传播和临床过程区分了这两种形式.
- 在IFNGR1基因型,细胞对干扰素的反应和临床表现之间存在强烈的相关性.
更多相关视频
12:49Mutagenesis and Analysis of Genetic Mutations in the GC-rich KISS1 Receptor Sequence Identified in Humans with Reproductive Disorders
Published on: September 4, 2011
07:26High-resolution Melting PCR for Complement Receptor 1 Length Polymorphism Genotyping: An Innovative Tool for Alzheimer's Disease Gene Susceptibility Assessment
Published on: July 18, 2017
相关概念视频
Receptor Downregulation in MVBs
The EGFR can initiate signaling pathways that lead to cell proliferation, migration, and differentiation. Overexpression of EGFR stimulates cells to proliferate. Excessive EGFR activation may...
Drug Toxicity: Risk factors
Toxidromes: Clinical Features
Mitral Regurgitation II: Clinical Features and Diagnostic Tests
Cardiomyopathy IV: Restrictive Cardiomyopathy
Chronic Kidney Disease II: Clinical Manifestations
